Topic: HALOZYME THERAPEUTICS
7 results were found.
Halozyme Therapeutics to buy Antares Pharma in $960mn deal - April 13, 2022
Halozyme Therapeutics Q1 revenue up greatly - May 11, 2021
Halozyme Therapeutics Q4 revenue $53.7 million - February 25, 2020
Halozyme Therapeutics names Matt Posard to board - March 29, 2013
Halozyme Therapeutics realigns management - December 8, 2010
William F. Daly joins Halozyme Therapeutics - October 28, 2010
Halozyme Therapeutics: Jonathan Leff new vice president, chief medical officer - July 27, 2009